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Aleutian  Mink  Disease  Virus  (AMDV)  is  a frequently  encountered  pathogen  associated  with  commercial
mink  breeding.  AMDV  infection  leads  to increased  mortality  and  compromised  animal  health  and  welfare.
Currently  little  is  known  about  the  molecular  evolution  of the virus,  and  the  few existing  studies  have
focused  on limited  regions  of the viral  genome.
This  paper  describes  a  robust,  reliable,  and  fast  protocol  for  ampliﬁcation  of the  full  AMDV  genome
using  long-range  PCR.  The  method  was  used  to generate  next  generation  sequencing  data  for  the  non-
virulent  cell-culture  adapted  AMDV-G  strain as well  as  for the virulent  AMDV-Utah  strain.  Comparisons
at  nucleotide-  and  amino  acid  level  showed  that, in agreement  with  existing  literature,  the highest  vari-
ability  between  the  two  virus  strains  was  found  in  the  left open  reading  frame,  which  encodes  thehole genome sequencing non-structural  (NS1–3)  genes.  This  paper  also  reports  a number  of differences  that potentially  can  be
linked  to virulence  and host  range.
To the  authors’  knowledge,  this  is the  ﬁrst study  to  apply  next  generation  sequencing  on the  entire
AMDV  genome.  The  results  from  the  study  will  facilitate  the development  of new  diagnostic  tools  and
can  form  the  basis  for more  detailed  molecular  epidemiological  analyses  of  the  virus.
©  2016  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND. Introduction
Aleutian Mink Disease (AMD), sometimes referred to as Plas-
acytosis, is worldwide the most important disease in the mink
arming industry. The disease affects mink of all ages and is caused
y Aleutian Mink Disease Virus (AMDV), a single stranded DNA
irus belonging to the family Parvoviridae (Bloom et al., 1980) genus
mdoparvovirus species Carnivore amdoparvovirus 1. Viral entry
s respiratory, oral, or via the placenta (Broll and Alexandersen,
996). Infection results in a harmful activation of the immune sys-
em leading to hypergammaglobulinaemia and systemic vascular
iseases and glomerulonephritis. Animal welfare is reduced and
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infected animals either die due to organ failure or become persis-
tently infected carriers transmitting the virus within and between
herds (Decaro et al., 2012). Like other parvoviruses AMDV replicates
only in dividing cells where it utilizes the host cell’s transcription
machinery. Multiple parvoviruses can infect the same host, and
this is believed to contribute to the high recombination rate shown
for parvoviruses compared to other DNA viruses (Shackelton et al.,
2007). AMDV consists of two  large open reading frames (ORF’s);
the left ORF (nucleotide 116–1975) coding for the non-structural
(NS) proteins involved in gene regulation and replication, and the
right ORF (nucleotide 2241–4346) coding for the viral capsid pro-
teins (VP), and three smaller central ORF’s (Alexandersen et al.,
1988; Bloom et al., 1988). In Denmark AMDV is a pathogen that
is monitored by a mandatory national control program (Danish
Executive Order 1447 of 15/12/2009, 2009). Brieﬂy, the program
requires all farms to conduct screening of their animals at regu-
lar intervals according to the disease status of the region. Positive
farms undergo a more intensive monitoring and are encouraged to
depopulate followed by a thorough cleaning and disinfection. Given
that parvoviruses are highly contagious and very resistant to envi-
ronmental factors, managing AMDV imposes large costs on the fur
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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Fig. 1. Gel electrophoresis of PCR amplicons. A 1% agarose-gel showing the long-
range PCR amplicons, fragment sizes are indicated with a 1 kb plus ladder. Lanes
0  represent negative control samples, lane 1 is AMDV-G ampliﬁed in one fragment
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Table 1
The primer sequences designed in the present study and the sizes of the expected
amplicons for the applicable combinations. All primers have been designed with the
Primer 3 software using the AMDV-G genome with accession number NC001662 as
reference. Forward primers are indicated F, reverse primers R.
Primer Positions
(NC 001662)
Primer sequence
(5′-3′)
Amplicon
size (bp)
F1 77-97 CGCTTCGCGCTTGCTAACTTC
R1 1814-1793 GCTCTGCGTGAGCGTTTGTTTC
F1  + R1 77-1814 1735
F2  1502-1525 CCGGGGGGCACTGGAAAAACCTTG
R2 3317-3296 GCAGAGAGGAGGTAGCCCCAAG
F2  + R2 1502-2217 1816
F3  2934-2953 GCGTCGTTACAGGTTGCTTT
R3 4467-4448 TTAATCCGCCACTTTCTGGT
F3  + R3 1534
R5 4462-4439 CCGCCACTTTCTGGTAAAATAAGG
F1  + R2 3240primers F1 + R3), lane 2A and 2B is AMDV-Utah ampliﬁed in two fragments; primers
1  + R2 and F2 + R3, respectively, and lane 3 is AMDV-G ampliﬁed in one fragment
ith primers F1 + R5.
ndustry (Decaro et al., 2012). The transmission patterns of AMDV
etween farms are not fully elucidated, and outbreak investigation
s currently hampered by lack of sensitive tools for detection and
yping of the virus. Previous studies have focused on smaller and
onserved parts of the AMDV genome (Christensen et al., 2011;
nuuttila et al., 2015; Leimann et al., 2015; Oie et al., 1996) and
herefore have produced data less suitable for typing. In addition,
here are methods for characterisation of the AMDV genome using
estriction fragmentation (Aasted, 1980) and Sanger sequencing
Alexandersen et al., 1988) but since they yield genetic information
or limited stretches of the genome, they too provide less resolution
han full genome sequencing. Next generation sequencing (NGS) is
 powerful tool that has become cheaper and more easily available
nd it has successfully been applied to characterise entire genomes
f other viruses and the genetic information obtained has been used
o improve preventative measures (Escobar-Gutiérrez et al., 2012;
akhesara et al., 2014; Kvisgaard et al., 2013).
To the authors’ knowledge, the whole AMDV genome has not
reviously been sequenced using NGS. The aim of this study was to
evelop a fast, sensitive high-through-put method for full genome
equencing of the AMDV genome by NGS to lay the foundation for
uture development of tools for outbreak investigation, determina-
ion of virulence markers, and for development of more sensitive
iagnostic tests and robust phylogenetic analyses.
. Material and methods
.1. Virus isolates
In order to establish an as universal method as possible two
MDV isolates with very different phenotypes, and hence pre-
umably also different genotypes, were selected. The non-virulent
ell-culture adapted strain AMDV-G (cell culture isolate, passage
0) was obtained from The Research Foundation of the Danish
ur Breeders’ Association/Antigen Laboratory (Glostrup, DK), while
he highly virulent AMDV-Utah isolate (antigen) was provided
y emeritus Professor Bent Aasted (Copenhagen, DK). Total DNA
as extracted using the QIAmp® MinElute Virus Spin Kit (Qiagen,
ilden, D) according to the manufacturer’s instructions, and the
nal DNA elution was performed with 50 L low TE-buffer.F2  + R3 1946
F1 + R3 4390
F1  + R5 4385
2.2. DNA ampliﬁcation
A long-range PCR covering about 91% of the AMDV genome
(nucleotide position 98–4467, Table 1) was developed. The use
of speciﬁc PCR ampliﬁcation is important for future ﬁeld appli-
cations as it avoids host DNA and attains a sufﬁcient amount of
double stranded DNA for the preparation of a sequencing library.
The AMDV-genome was  ampliﬁed in either a single or two over-
lapping fragments. The PCR primer-sequences are listed in Table 1
and were designed using the Primer3 software (Ye et al., 2012) with
AMDV-G (accession no. NC001662) (Bloom et al., 1988) as refer-
ence genome. PCR reactions were setup as follows: 25 L GoTag®
Long PCR Master Mix  (cat. no. M4021, Promega, Madison, WI), 2 M
primer F and R, 5 L DNA template, and distilled water up to a
total sample volume of 50 L. Final cycling conditions were; ini-
tial denaturation at 95 ◦C for 2 min, 38 cycles of 30 s denaturation
at 95 ◦C, 20 s annealing at 58 ◦C, and 30 s extension at 72 ◦C, fol-
lowed by a ﬁnal extension step for 10 min  at 72 ◦C. All reactions
were performed in a Bio-Rad CFX96 Touch instrument (Bio-Rad
Laboratories, Inc., Hercules, CA).
The PCR products were analysed on 1% agarose gels stained
with ethidiumbromide, and puriﬁed according to the manufac-
turer’s instructions using the QIAquick® PCR Puriﬁcation Kit or
the QIAquick® Gel extraction kit (both from Qiagen, Hildren, D)
depending on if there was  a single product or not. DTU  (Techni-
cal University of Denmark) Multi-Assay Core (Lyngby, Denmark)
prepared the sequencing libraries according to the manufacturer’s
instructions and sequenced the samples on a 318-chip using the
Ion Torrent PGM® (Life Technologies, Carlsbad, CA). The technol-
ogy was chosen because it is easily accessible, cheap and fast, which
are all-important factors for the future intended use in ﬁeld applica-
tions. The region between positions 2470 and 2520 displayed very
low read coverage in the Ion Torrent sequencing (possibly due to
the nucleotide composition in this area) and we  therefore Sanger-
sequenced PCR-products spanning this region using primers F2 and
R2 (Table 1) to verify the Ion-torrent ﬁndings.
2.3. Data analysis
Raw data in fastq-format were quality checked with FastQC
version 0.10.1 and trimmed based on length (100–400 bp) and qual-
ity (average quality score >20) using Prinseq-lite (Schmieder and
Edwards, 2011). Primer sequences were removed using Cutadapt
version 1.4.1 (Martin, 2011). Reads were corrected for sequencing
errors using RC454, and assembled with the associated Mosaik2
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Fig. 2. Read coverage-plots. Coverage-plots showing the depth of coverage (Y-axis) at each sequenced nucleotide position in the genome (X-axis). The dip in coverage between
position 2470 and 2520 is assumed to be caused by the ion-semiconductor sequencer having problems to read this homopolymeric region.
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tretches of G’s). Consensus sequences for each triplicate of AMDV-G, for AMDV-Utah
t  position 2489 in the Sanger sequence for the third replicate of AMDV-G (3(3)) is 
ssembler (Henn et al., 2012). The error-corrected reads were
hen mapped using BWA  (Li, 2013) to the AMDV-G reference
NC001662) cut between the 5′ and 3′ annealing sites for primers
1 and R3 respectively (Table 1). For each sample a consensus
equence was generated using Vcf-tools 0.1.12a (Danecek et al.,
011). Multiple alignments of the full genomes was done using
AFFT v7.205 (Katoh and Standley, 2013). For additional compar-
sons, the following AMDV-Utah sequences were downloaded from
he NCBI database: U39015.1, X77083.1 and Z1827.6.1. Alignments
ere visualized in Geneious 7.1.5. (Kearse et al., 2012).
. Results
.1. Speciﬁcity of the PCR products
A long range PCR assay for speciﬁc ampliﬁcation of the AMDV
enome was developed. Originally, three sets of primers spanning
he AMDV genome were designed and the non-coding palindromic
′- and 3′-ends (Bloom et al., 1990) which are known to inter-
ere with PCR-ampliﬁcation were excluded. After running a matrix
ith the possible combinations of forward and reverse primers,
he optimal primer pairs was selected as assessed by gel elec-
rophoresis. PCR cycling conditions were optimized by running an
nnealing-temperature gradient and ampliﬁcation of PCR-products
f the expected sizes were conﬁrmed by gel electrophoresis (Fig. 1).
he PCR reactions that produced one speciﬁc product were directly covering the homopolymeric region between positions 2470 and 2520 (repeated
for their corresponding Sanger generated sequence. The single nucleotide difference
ghted.
processed for sequencing. In cases where additional PCR-products
were present, the band of the expected size was extracted from
the gel prior to sequencing (Fig. 1). The AMDV-G and AMDV-Utah
sequences sequenced in this study was ampliﬁed using primer
F1 + R3 (Table 1), however during further assay optimisation better
yields of PCR-product was achieved using primer F1 and R5 (assed
by gel electrophoresis, Fig. 1). Despite the presumed genetic differ-
ences between the two viral isolates they both ampliﬁed well using
these primers (Fig. 1).
3.2. Sequence quality and coverage
AMDV-G DNA was extracted in triplicates, and each individual
sample was PCR-ampliﬁed and sequenced. AMDV-Utah DNA was
extracted once, PCR-ampliﬁed, and sequenced. Primer-sequences
and low quality reads were removed prior to data analysis. The
data quality was  overall high, and for each sample approximately
99% of the trimmed and quality ﬁltered reads mapped to the
AMDV-G reference. Coverage-plots for each of the four samples
showed a dip in coverage between nucleotide positions 2470 and
2520 (Fig. 2). However, the Sanger-generated sequences spanning
this region matched the sequences produced by the Ion Torrent,
with the exception of a single nucleotide difference in the Sanger
sequence for AMDV-G replicate no. 3 (Fig. 3). The quality score for
this deviating base (G) was low (eight), while the scores for the cor-
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o  the reference AMDV-G genome. Nucleotide positions: 116–1975 left ORF (L-ORF
 (M-ORF 2), and 2241–4346 right ORF (R-ORF).
esponding base in the other two Sanger sequences were 38 and
0, and therefore indicates an error from the Sanger sequencing.
he AMDV-G and AMDV-Utah sequences have the following acces-
ion numbers: KU513985, KU513986, KU513987, and KU513988,
espectively.
.3. Sequence analysis
The alignments showed an overall high sequence similarity
99% homology) between the AMDV-G samples generated in this
tudy and the previously published AMDV-G sequence obtained by
anger sequencing (NC001662). The robustness of the protocol was
emonstrated by aligning the sequences obtained from sequencing
MDV-G in triplicates, and a deviation of a single nucleotide was
ound, out of the total 3369. An overview of the AMDV genomic
rganization is provided in Fig. 4. The AMDV-G triplicates and
MDV-Utah were compared on nucleotide and amino acid level
Table 2), and unless other is indicated, the results and discus-
ion compare the AMDV-G and AMDV-Utah strains generated in
he present study..4. NS1 gene
The left open reading frame encodes for NS1–3. NS1 is the
ajor regulatory protein in parvoviruses and it plays an impor-(ORF’s) and how the major proteins are spliced together. Nucleotide positions refer
5–1825 small ORF (S-ORF), 1993–2209 mid ORF 1 (M-ORF 1), 1983–2204 mid  ORF
tant role in viral replication during infection (Fields et al., 2007;
Gottschalck et al., 1994). In addition to conﬁrming a number of pre-
viously reported differences between AMDV-G and AMDV-Utah,
the present study also report novel ﬁndings as demonstrated in
Table 2.
In the purine binding pocket between amino acids 421–492
(Gottschalck et al., 1994) a single change (F481L) between AMDV-
G and AMDV-Utah was observed in addition to a single change
(F430L) between ADMV-G and the AMDV-G reference (Table 2).
Overall, the purine binding region, including the GKRN-region
between amino acids 435–440 and its purine binding pocket, was
well conserved in the sequences produced in the present study
(Fig. 5, panel A). In agreement with previous studies of the distri-
bution of changes in NS1 (Gottschalck et al., 1994), a higher degree
of variability was demonstrated in the N- and C-terminals of NS1
compared to in the middle (Fig. 5 panel A).
3.5. VP2 gene
In addition to conﬁrming a number of previously reported dif-
ferences between AMDV-G and AMDV-Utah, some of which have
been proposed to inﬂuence virulence and host range (overview
in Table 2), this study report novel differences in the VP2 gene.
The N-terminus of VP2, amino acid 1–220, has been suggested to
play a role in AMDV host range and culturing ability (Bloom et al.,
E.E. Hagberg et al. / Journal of Virological Methods 234 (2016) 43–51 47
Table  2
Overview of the nucleotide (nt) changes reported in the present study, including changes in the affected amino acids (aa) for the two most well described genes; NS1 and
VP2.  Absolute nucleotide positions refer to the AMDV-G reference genome (NC001662). Dash/es means no change in comparison to the AMDV-G reference genome. Isolates
sequenced in the present study are indicated by *, and observations without a reference originates from the present study and hence are novel.
Absolute nt pos. Codon pos. NC001662 AMDV-Utah* AMDV-G* Reference accessions
nt aa nt aa nt aa
L-ORF
179–181 AGC S - - G- - G
221–223 NS1/2 = 6 ATT I C- - L - - - - Z18276.1, X77083.1
275–277 NS1/2 = 24 AAC N GCT A - - - -
290–292 NS1/2 = 29 GTT V C- - L - - - -
293–295 NS1/2 = 30 GCC A - -T - - - - -
299–301 NS1/2 = 32 TTG L C-A - - - - -
353–355 NS1/2 = 50 CCG P - -A - - - - - Z18276.1, X77083.1
368–370 NS1/2 = 55 ACC T - -T - - - - -
389–391 NS1 = 62 GCT A - -A - - - - -
395–297 NS1 = 64 GAC D - -T - - - - -
410–412 NS1 = 69 AAT N -CC T - - - -
416–418 NS1 = 71 ACA T -T- I - - - -
431–433 NS1 = 76 CAC H - -G Q - - - - Z18276.1, X77083.1
440–442 NS1 = 79 AAC N - -A K - - - -
443–445 NS1 = 80 AAT N G- - D - - - -
470–472 NS1 = 89 TTG L - -A - - - - -
485–487 NS1 = 94 CTG L G- - V - - - -
491–493 NS1 = 96 ATT I G- - V - - - - C- -/L Z18276.1, X77083.1
506–508 NS1 = 101 AAA K - -G - - - - -
509–511 NS1 = 102 AGC S - -T - - - - -
524–526 NS1 = 107 AGT S GC- A - - - - -A-/N Z18276.1, X77083.1
527–529 NS1 = 108 AAC N G-T D - - - -
533–535 NS1 = 110 GTT V A- - I - - - -
539–541 NS1 = 112 TTA L - -C F - - - -
542–544 NS1 = 113 ATT I - -C - - - - -
572–574 NS1 = 123 CAA Q - -C H - - - -
650–652 NS1 = 149 TTT F - -G L - - - -
653–655 NS1 = 150 ATG M - -T I - - - -
659–661 NS1 = 152 AGA R -A- K - - - -
668–670 NS1 = 155 AAA K -G- R - - - -
680–682 NS1 = 159 GTT V -C- A - - - - C- -/L Z18276.1, X77083.1
686–688 NS1 = 161 TAT Y -A- F - - - -
707–709 NS1 = 168 ATA I CA- Q - - - -
713–715 NS1 = 170 GAT D - -C - - - - -
728–730 NS1 = 175 GAA E - -G - - - - -
731–733 NS1 = 176 GAT D -CC A - - - -
734–736 NS1 = 177 AGA R -A- K - - - -
740–742 NS1 = 179 AAG K - -T N - - - -
746–748 NS1 = 181 CTA L T-G - - - - -
767–769 NS1 = 188 GGA G - -G - - - - -
776–778 NS1 = 191 AAG K - -A - - - - -
788–790 NS1 = 195 TAT Y - -C - - - - -
791–793 NS1 = 196 TTT F -A- Y - - - -
818–829 NS1 = 205 AAT N - -C - - - - - Z18276.1, X77083.1
830–832 NS1 = 209 CAC H AC- T - - - -
836–838 NS1 = 211 AGA R - -T S - - - -
845–847 NS1 = 214 ACA T GT- V - - - -
848–859 NS1 = 2015 TTC F A-A I - - - -
878–890 NS1 = 225 AAT N C- - H -
881–883 NS1 = 226 ACA T -AG K - -
884–886 NS1 = 227 GAT D - -A E - -
887–889 NS1 = 228 AGT S G- - G - -
902–904 NS1 = 233 TTT F -A- Y - -
920–922 NS1 = 239 GGC G - -T - - -
923–925 NS1 = 240 ATT I - -C - - -
925–928 NS1 = 241 GTT V A- - I - -
953–955 NS1 = 250 AAA K - -G - - -
954–056 NS1 = 251 ACT T G-C A - -
974–976 NS1 = 257 TTA L - -G - - -
980–982 NS1 = 259 GAG E - -A - - -
1007–1009 NS1 = 268 AAT N G- - D - -
1025–1027 NS1 = 274 GGC G - - - - A- - S
1070–1072 NS1 = 289 ACA T T- - S - -
1106–1108 NS1 = 301 GCT A - -A - - - - -
1109–1111 NS1 = 302 ACT T - -C - - - - -
1130–1132 NS1 = 309 GAA E - - - - - -C D
1154–1156 NS1 = 317 CCT P - - - - - -G -
1181–1183 NS1 = 326 AGT S -A- N - - - - Z18276.1, X77083.1
1337–1339 NS1 = 378 ATT I - -G M - - - - Z18276.1, X77083.1
1493–1495 NS1 = 430 TTC F - - - - C- - L
1646–1648 NS1 = 481 TTT F C- - L - - - - Z18276.1, X77083.1
1703–1705 NS1 = 500 GAC D - -T - - - - - Z18276.1, X77083.1
48 E.E. Hagberg et al. / Journal of Virological Methods 234 (2016) 43–51
Table 2 (Continued)
Absolute nt pos. Codon pos. NC001662 AMDV-Utah* AMDV-G* Reference accessions
nt aa nt aa nt aa
2143–2145 NS1 = 620 TGC C - - - - -A- Y
2161–2163 NS1 = 626 AGT S G- - G - - - - Z18276.1, X77083.1
M-ORF1
2143–2145 NS1 = 620 TGC C - - - - -A- Y
2161–2163 NS1 = 626 AGT S G- - G - - Z18276.1, X77083.1
2179: GCA/A to CCG/P Z18276.1, X77083.1
2218–2220 non-coding ATA I G- - V G- - V Z18276.1, X77083.1
M-ORF2
2142–2144 NS2 = 94 CTG L - - - - - -A -
2160–2162 NS2 = 100 GAG E -G- G - - - - Z18276.1, X77083.1
2217–2219 non-coding AAT N -G- S -G- S Z18276.1, X77083.1
R-ORF
2631–2633 VP2 = 76 GAC D - -T - - - - - Z18276.1, U39015.1
2673–2675 VP2 = 90 AAA K - - - - C- - Q
2679–2681 VP2 = 92 CAT H - - - - - - - H GC-/A Z18276.1, U39015.1
2685–2687 VP2 = 94 CAA Q - - - - - - - - A- -/K Z18276.1, U39015.1
2748–2750 VP2 = 115 TAT Y -T- F - - - - Z18276.1, U39015.1
2751–2753 VP2 = 116 ATA I T- - L - - - -
3459–3461 VP2 = 352 ATT I G- - V - - - - Z18276.1, U39015.1
3585–3587 VP2 = 394 CAA Q - - - - - -G -
3588–3590 VP2 = 395 CAC H - -G Q A- - N Z18276.1, U39015.1
3693–3695 VP2 = 430 TAC Y - - - - - -T -
3696–3698 VP2 = 431 TAC Y - - - - ATT I
3705–3707 VP2 = 434 AAT N CAT H - - - - Z18276.1, U39015.1
3876–3878 VP2 = 491 AAC N G- - D - - - - GAG/E Z18276.1, U39015.1
3975–3977 VP2 = 524 CCG P - -A - - -A - Z18276.1, U39015.1
4005–4007 VP2 = 534 CAT H G- - D - - - - Z18276.1, U39015.1
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r4125–4127 VP2 = 574 AAT N - - - 
4263–4265 VP2 = 620 AAG K AAC 
4305–4307 VP2 = 634 ATA I - - - 
998), and the present study conﬁrm some, but not all, of the pre-
iously reported differences between AMDV-G and AMDV-Utah in
his region (Table 2). In addition a novel change in AMDV-Utah
T116L) is reported here.
Amino acid 420 have been proposed to increase viral ﬁtness by
revention of caspase cleavage (Cheng et al., 2010), however in
greement with other studies (Bloom et al., 1988; Oie et al., 1996;
ang et al., 2012) that particular difference between AMDV-G and
MDV-Utah was not observed here either. VP2 amino acid 428–446
unctions as a small part of the capsid which has also been suggested
o be important for immunopathogenesis by deﬁning AMDV host
ange (McKenna et al., 1999). The present study conﬁrms a previ-
usly reported difference, N343H, in this area, but whether or not
his change results in increased pathogenicity is currently unknown
Bloom et al., 1988; Oie et al., 1996; Sang et al., 2012).
In addition to the above-mentioned differences between AMDV-
 and AMDV-Utah, additional differences were observed in the
P2 amino acid sequence between the AMDV-G reference and the
MDV-G strain from the laboratory (e.g. K90Q, H395N and D574N).
t is currently unknown if there is a ﬁtness effect associated to these
hanges (e.g. adaption to tissue-culture conditions).
The overall lower conservation of AMDV NS-genes compared to
ther parvoviruses is supported in the present study by the higher
egree of variability in the left ORF compared to in the right ORF,
hich was even more striking on amino acid level (Fig. 5, panel A).
.6. Regulatory elements
Previous studies have identiﬁed eight TATA-boxes in the AMDV
enome; two conﬁrmed functional at nucleotide 154 (TATAA) and
729 (TATTAA), and six additional boxes at nucleotide 665, 818,
546, 4136, 4394, and 4468 (AATAAA) with unknown function
Bloom et al., 1988). In the AMDV-Utah sequence, a previously
eported difference to AMDV-G in TATA-box 818 (T820C) (Bloom- G- - D
N - - - - Z18276.1, U39015.1
- - -G M
et al., 1988; Gottschalck et al., 1994) is conﬁrmed, and a previously
not described change in the 665 box (A669G) is reported. But since
the function of these TATA boxes is unknown, the importance of
these differences remains to be investigated. The 4468 box was  not
included in the sequences generated in the present study.
A P3 promotor that initiates transcription of all mRNA have
previously identiﬁed at nucleotide 151–160 (p3, GTATATAAGC)
(Bloom et al., 1988), in addition to a more uncertain promotor P36
around nucleotide 1744 (Bloom et al., 1988; Qiu et al., 2006). In
the present study these promotors were fully conserved. However
at the suggested transcription initiation site at nucleotide 179 a
change (A179G) is reported in the present AMDV-G strain (Table 2)
compared to the reference AMDV-G genome.
Internal polyadenylation sites (pA)p’s at nucleotide 2561 and
4391 have been suggested to play a major role in AMDV replication
(Huang et al., 2012). Studies in the parvovirus Minute Virus of Mice
(MVM)  shows that the above mentioned NS1 GKRN-region contains
a NS1 recognition site at amino acids 337–344 (ACCAACCA), which
together with an upstream nicking site initiates viral replication
(Christensen et al., 1997). All of these sites were conserved in the
two viruses investigated here, and therefore should not have any
effect on the increased virulence of AMDV-Utah.
4. Discussion
This paper describes a fast and robust protocol for next gen-
eration sequencing of the near full length AMDV genome and the
subsequent data analysis. The protocol was veriﬁed by gel elec-
trophoresis, complimentary Sanger sequencing, and by sequence
analysis. The prototypic non-virulent cell-culture adapted strain
AMDV-G was  used as a model virus, and for comparison and to
investigate genetic virulence markers the highly virulent AMDV-
Utah strain was also sequenced. Due to the presence of secondary
structures and palindromic motifs at the 3′ and 5′ ends, approxi-
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ately 91% of the viral genome was ampliﬁed; including all known
oding regions (Alexandersen et al., 1988; Bloom et al., 1988).
This study conﬁrm some of the previously reported nucleotide
nd amino acid differences between AMDV-G and AMDV-Utah
Table 2) and no major deviations in the suggested genomic reg-
latory regions were observed (Bloom et al., 1988). Therefore, one
an speculate that the increased virulence of AMDV-Utah compared
o AMDV-G is not due to differences in gene regulation but rather
n protein level.ents at protein level for each of the NS1 (Panel A) and VP2 (Panel B) genes for the
-Utah (3) strain sequenced in this study.
However, some nucleotide and amino acid differences was
observed between the previously published Sanger generated
AMDV-G and AMDV-Utah genomes and the genomes sequenced
in this study, which could be a result of further cell-culture adap-
tation of both strains or due to the use of different sequencing
technologies. One speciﬁc change of interest is the A179 G seen in
our AMDV-G strain (Table 2), as it might inﬂuence the translation
initiation codon at nt 179–181. Another change that might be of
importance is the F430L. It resides in close proximity to the con-
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erved ATP-binding pocket and GKRN region between amino acids
35–440, which has been suggested to be essential for the NS1 pro-
ein and viral DNA replication due to its ATP- and GTP binding sites
nd its ATPase function (Gottschalck et al., 1994).
There is some disagreement in the literature regarding the frame
nd sequence of the ﬁrst three amino acids of the AMDV-G VP1
ene, in that one study suggests the start to be MSK  in frame 2
Huang et al., 2012) (accession number JN040434.1), while another
tudy suggests HHN in frame 3 (Schuierer et al., 1997) (accession
umber X97629.1). The ﬁrst option would be more similar to e.g.
uman parvovirus B19, in which the VP1-unique region (starting
ith an MSK) is encoded in another frame, while the remaining
rotein is identical to that of VP2 (as depicted in Fig. 4). In the second
ption, starting with amino acids HHN, the whole VP1 protein is
ncoded in the same frame as that of VP2, but with an additional 55
mino acids in the N-terminal. However, in this sequence there is no
tart codon (Fig. 4), and therefore it is sensible to assume that option
ne (MSK) is more correct. In human parvovirus B19 this unique
P1 N-terminal has been identiﬁed as key for viral entry (Leisi et al.,
013), and studies in AMDV suggest its importance as it provides
hospholipase A2 enzyme activity which modiﬁes the endosome
embrane thereby mediating capsid release (Fenner’s Veterinary
irology, 2011). It has further been suggested that AMDV’s ability
o grow in cell culture is regulated by the N-terminal of the VP2
ene (Bloom et al., 1998), and one can therefore speculate that the
P1 unique terminal could be linked to in vivo infectivity.
Both the VP and the NS proteins have been suggested to
e involved in determining the viral host range and inﬂuence
athogenicity (Fields et al., 2007). For example, it has been shown
hat knockout of the NS1-gene resulted in failure to produce
eplicative form AMDV DNA (Huang et al., 2014). In the present
tudy, the majority of nucleotide and amino-acid differences
etween AMDV-G and AMDV-Utah were in the left ORF. This is in
greement with previous studies reporting that the non-structural
NS) proteins of AMDV-G and AMDV-Utah have different molecu-
ar weights (Alexandersen et al., 1986), and are less conserved than
n other parvoviruses (Gottschalck et al., 1994). Interestingly, it is
nown that the AMDV right ORF is more conserved despite contain-
ng virulence factors important for the viral entry (Gottschalck et al.,
991; Oie et al., 1996). These ﬁndings indicate that the virulence of
MDV-Utah may  not be primarily due to increased infectivity since
his function depends primarily on the VP genes. Instead the dif-
erence in virulence could e.g. be linked to the NS proteins that are
nvolved with virion assembly, release, unpacking, or the ability to
void host cell responses.
The protocols developed in this study enable viral DNA to be
xtracted and ampliﬁed from primary sample material and by that
voiding the use of labour intensive cloning to amplify the viral
NA prior to sequencing. The PCR-ampliﬁcation step is also useful
s the concentration of viral DNA in viraemic animals is not suf-
cient to directly act as template for next generation sequencing.
he viral strains used to establish this protocol have very differ-
nt phenotypes and despite the expected genetic difference both
trains ampliﬁed well. This indicates a high degree of conserva-
ion in the primer-annealing region, which is further supported
y on-going work successfully amplifying AMDV ﬁeld strains (data
ot shown). There are however potential biases when using PCR
mpliﬁed DNA as input for sequencing, e.g. for investigating quasi-
pecies. But this is of less importance if the resulting data will be
sed for comparing sample consensus sequences, as in the present
tudy. The ion-semiconductor technology is known to have difﬁcul-
ies to accurately PCR amplify and read homopolymers (Quail et al.,
012), and especially G’- and C’-rich regions as between position
470 and 2520 in the AMDV-G reference genome. Therefore the
obustness of the protocols was demonstrated by processing the
MDV-G strain in triplicates and by sequencing the homopolymericcal Methods 234 (2016) 43–51
region in each sample using the complimentary Sanger sequencing
method. Since the NGS sequences from each sample were identi-
cal, and so were the Sanger generated fragments (the latter with
the exception of one erroneous base), it was  concluded that the dip
in coverage was caused during the sequencing, and not by the PCR
ampliﬁcation. Thus, it would be beneﬁcial to disregard this region
in alignments when the Ion Torrent technology is used, and for the
development of molecular tools.
In conclusion, this is to the authors’ knowledge the ﬁrst study
to describe the entire coding sequence of the AMDV genome
using next generation sequencing. The study provides a robust
and fast method for generating whole genome sequences of AMDV
from various DNA sources and will create value by allowing for
phylogenetic analysis with higher resolution and by facilitating
development of new diagnostic tools.
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